Data / Research funding / Maryland / The Emmes Company, LLC
The Emmes Company, LLC: 23 NIH awards ($388.3M), fiscal years 2021 to 2026
The Emmes Company, LLC in Rockville, MD is funded under 23 NIH awards ($388.3M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- NBQCBJ6FXBU4
- State
- Maryland
Awards
23 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Statistical and Data Coordinating Center (SDCC) for Clinical Research in Infectious Diseases: Mpox Clinical Research Activities | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $150,331,625 | March 1, 2021 | February 28, 2026 | EWELL, MARIAN | reporter.nih.gov |
| CLINICAL TRIALS AND INFORMATION MANAGEMENT SUPPORT-Moonshot Funding | NIH | National Cancer Institute | 2021 to 2025 | $38,115,589 | June 1, 2021 | May 31, 2026 | VALMONTE, CLAUDIA | reporter.nih.gov |
| CCC TO 11 - CTN-0145: STANDARD VERSUS HIGH DOSE ED-INITIATED BUPRENORPHINE INDUCTION. POP: 8/28/23 - 8/27/27. | NIH | National Institute on Drug Abuse | 2021 to 2025 | $33,434,913 | August 28, 2023 | August 27, 2026 | JELSTROM, EVE | reporter.nih.gov |
| DSC MANAGEMENT AND SUPPORT. MARCH 1, 2025 TO FEBRUARY 28, 2026. N01DA-22-2253. TASK ORDER NO. 75N95025F00001 (TO25). | NIH | National Institute on Drug Abuse | 2022 to 2025 | $25,789,598 | March 1, 2025 | February 28, 2026 | reporter.nih.gov | |
| EO14042 DEVELOPMENT, STATISTICAL DESIGN, MONITORING AND COORDINATION OF VISION CLINICAL TRIALS AND EPIDEMIOLOGY RESEARCH | NIH | Office of the Director, National Institutes of Health | 2022 to 2025 | $25,277,032 | November 1, 2021 | October 31, 2026 | MENEZES, SUPRIYA | reporter.nih.gov |
| LOGISTICAL AND IT SUPPORT FOR THE NCI CENTRAL INSTITUTIONAL REVIEW BOARD (CIRB) | NIH | National Cancer Institute | 2021 to 2023 | $21,394,060 | September 1, 2019 | August 31, 2024 | VALMONTE, CLAUDINE | reporter.nih.gov |
| LOGISTICAL AND IT SUPPORT FOR THE NCI CENTRAL INDIVIDUAL REVIEW BOARD (CIRB) | NIH | National Cancer Institute | 2024 to 2025 | $18,014,450 | September 1, 2024 | August 31, 2026 | VALMONTE, CLAUDINE | reporter.nih.gov |
| NIDA DATA, STATISTICS, AND CLINICAL TRIAL SUPPORT CENTER MANAGEMENT AND SUPPORT. 03/01/2022 - 02/28/2023. N01DA-19-2250. TASK ORDER 75N95022F00001 (TO | NIH | National Institute on Drug Abuse | 2021 to 2022 | $14,328,957 | March 1, 2022 | February 28, 2023 | MCCORMACK, JENNIFER | reporter.nih.gov |
| TO4. CLINICAL COORDINATING CENTER FOR NIDA'S CLINICAL TRIALS NETWORK. CONTRACT TYPE: IDIQ TASK ORDER. POP: 8/15/24 - 8/14/29 | NIH | National Institute on Drug Abuse | 2024 to 2025 | $13,234,516 | July 16, 2025 | July 15, 2026 | reporter.nih.gov | |
| DATA COORDINATING CENTER TO PROVIDE SERVICES TO WORK COLLABORATIVELY WITH THE NATIONAL NEUROHIV TISSUE CONSORTIUM CLINICAL SITES TO PROVIDE MANAGEMENT AND DATABASE CAPABILITIES, SCIENTIFIC EXPERTISE, | NIH | National Institute on Drug Abuse | 2023 to 2025 | $11,232,511 | August 7, 2025 | August 6, 2026 | SHERMAN, SETH | reporter.nih.gov |
| IGF::OT::IGFEMMES NEIS-V | NIH | Office of the Director, National Institutes of Health | 2021 | $7,315,897 | November 1, 2016 | October 31, 2021 | HAMMEL, KERI | reporter.nih.gov |
| NINDS CENTER FOR CLINICAL TRIAL RESOURCES | NIH | National Institute on Drug Abuse | 2022 to 2025 | $7,088,164 | September 30, 2022 | September 29, 2026 | HEFNER, KATHRYN | reporter.nih.gov |
| Sickle Cell Disease Cure Initiative (SCDC) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $7,000,926 | September 30, 2017 | June 30, 2026 | COLEMAN-COWGER, VICTORIA HOPE | reporter.nih.gov |
| IGF::OT::IGF THE NATIONAL MYELODYSPLASTIC SYNDROMES (MDS) NATURAL HISTORY STUDY, DATA COORDINATING CENTER (DCC), TASK ORDER 03, SEPTEMBER 1, 2016-FEBRUARY 28, 2018 | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $4,930,056 | September 1, 2016 | December 31, 2025 | STABLIN, DON | reporter.nih.gov |
| DATA COORDINATING CENTER FOR THE PRENATAL AND CHILDHOOD MECHANISMS OF HEALTH DISPARITIES: RECRUITMENT AND FOLLOW-UP OF SECOND SUBCOHORT OF PREGNANT WOMEN AND THEIR PARTNERS | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2024 | $2,486,661 | August 16, 2024 | August 15, 2025 | SHERMAN, SETH | reporter.nih.gov |
| Continuation of The Collaborative Islet Transplantation Registry (CITR) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,399,074 | September 15, 2022 | June 30, 2027 | PAYNE, ELIZABETH HOLLY | reporter.nih.gov |
| DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT(BPCA) - PTN CUDDLE | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $1,859,558 | May 29, 2024 | May 28, 2025 | ANAND, RAVINDER | reporter.nih.gov |
| NINDS CENTER FOR CLINICAL RESEARCH | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,478,090 | September 30, 2017 | September 29, 2022 | CLEMONS, TRACI E | reporter.nih.gov |
| STATISTICAL AND DATA COORDINATING CENTER FOR CLINICAL RESEARCH ON INFECTIOUS DISEASES | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $802,360 | March 1, 2015 | February 28, 2021 | EWELL, MARIAN | reporter.nih.gov |
| Support Services for the NHLBI-Sponsored Data Science Institutional Review Board | NIH | National Heart, Lung, and Blood Institute | 2022 | $643,082 | May 1, 2018 | April 30, 2023 | COVINGTON, LAURA | reporter.nih.gov |
| Phase I/II Randomized, Prospective, Double-blinded, Sham-controlled Cross-over Study of Intravitreal Autologous Bone Marrow CD34+ Stem Cell Therapy for Retinal Vein Occlusion | NIH | National Eye Institute | 2021 to 2022 | $598,846 | June 15, 2018 | May 31, 2025 | MCCORMACK, JENNIFER BACIK | reporter.nih.gov |
| Production Assistance for Cellular Therapies (PACT) - Coordinating Center (CC) | NIH | National Heart, Lung, and Blood Institute | 2021 | $332,978 | July 1, 2016 | June 30, 2021 | LINDBLAD, ROBERT | reporter.nih.gov |
| CLINICAL TRIALS AND INFORMATION MANAGEMENT SUPPORT | NIH | National Cancer Institute | 2021 | $231,931 | June 16, 2016 | May 31, 2021 | VALMONTE, CLAUDINE | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 11 | $64,923,901 | 0 | $0 |
| 2024 | 14 | $82,338,189 | 0 | $0 |
| 2023 | 11 | $87,971,435 | 0 | $0 |
| 2022 | 16 | $83,126,572 | 0 | $0 |
| 2021 | 13 | $69,960,777 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Topics of its NIH awards
- Clinical Research
- Patient Safety
- Clinical Trials and Supportive Activities
- Neurosciences
- Drug Abuse (NIDA only)
- Substance Misuse
- Cancer
- Infectious Diseases
- Neurodegenerative
- Pediatric
- Rare Diseases
- Brain Disorders
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.